Find your next paid study

VA Office of Research and DevelopmentNCT05935761

~$75 – $1,800

Actual pay is set by the research site.

Phase 2

CBG and Attention: A Double-Blind, Randomized, Placebo-Controlled Trial Examining the Effects of Cannabigerol on Indicators of Attention-Deficit/Hyperactivity Disorder

The goal of this clinical trial is to evaluate the effects of Cannabigerol (CBG) on indicators of Attention-Deficit/Hyperactivity Disorder (ADHD) in a sample o…

Attention-Deficit/Hyperactivity Disorder

University of Arkansas, FayettevilleNCT06115603

~$75 – $2,000

Actual pay is set by the research site.

Thermogenic Responses to Fasting and Overfeeding in Women: a Potential Mechanism Contributing to Postmenopausal Weight Gain

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The…

Obesity

University of Colorado, DenverNCT06610162

Actual pay is set by the research site.

Mild Cognitive ImpairmentDementiaBPSD+2 more

Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD

The purpose of this study is to test the usefulness and the effect of Smart Virtual Reminiscence (SVR) therapy intervention on the Behavioral and Psychological…

Indiana UniversityNCT07499570

Actual pay is set by the research site.

DeliriumImpaired Cognition

Simultaneous Recumbent Cycling and Cognitive Training on Cognition in Intensive Care Unit Survivors: a Randomized Control Trial

Intensive care units (ICU) provide life-saving care for nearly five million people annually. Up to 80% of patients receiving care in an ICU experience at least…

University of Missouri, Kansas CityNCT04556227

Actual pay is set by the research site.

Phase 1

The Impact of Phosphate Metabolism on Healthy Aging

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial…

HypophosphatemiaRicketsHypercalciuria+2 more

Yale UniversityNCT03771105

~$150 – $3,000

Actual pay is set by the research site.

Alzheimer DiseaseCognitive DeclineAging

Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease

The investigators will study performance on computerized cognitive tasks in healthy participants of different ages to gather normative data for newly developed…

Neurobehavioral Systems, Inc.NCT04800588

~$10 – $1,050

Actual pay is set by the research site.

Phase 2

A Phase 2 Study of Microsatellite Stable Colorectal Cancer (Stage 2 or 3) With Radiographic Occult Molecular Residual Disease Treated With Botensilimab (AGEN1181; Bot) Plus Balstilimab (AGEN2034, Bal) After Established Definitive Therapy (COMBAT Study)

This phase II trial tests the effect of the botensilimab in combination with balstilimab in treating patients with stage II/III colorectal adenocarcinoma with …

Colorectal AdenocarcinomaStage II Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8

National Cancer Institute (NCI)NCT07551596

~$75 – $1,800

Actual pay is set by the research site.

PRecision-Controlled Ventilation to Enhance Cardiac Arrest Intervention and Survival IN CPR: A Multi-Center Randomized Controlled Trial

Cardiac arrest is a life-threatening emergency that requires immediate treatment with cardiopulmonary resuscitation (CPR). While chest compressions circulate b…

Cardiac Arrest (CA)

Rush University Medical CenterNCT07088120

Actual pay is set by the research site.

Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases

The RBBK study is a non-interventional, prospective study that will characterize disease state biomarker levels from aqueous humor, vitreous humor, intraoperat…

Other Retinal DisordersRetinal DiseaseRetinal Vascular Disorder

Greater Houston Retina ResearchNCT06796673

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Phase 1, Open-label, Multicenter Clinical Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Anti-Cancer Activity of PQ203 in Patients With Advanced Solid Tumor Malignancies

The primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple negative breas…

Triple Negative Breast Cancer (TNBC)Advanced Solid Tumors Cancer

ProteinQure Inc.NCT07190469

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Open-label Intrathecal Administration of MELPIDA to Determine Its Safety and Efficacy for Patients With Spastic Paraplegia Type 50 (SPG50) Caused by Mutation in the AP4M1 Gene.

MELPIDA is proposed for the treatment of subjects with SPG50 and targets neuronal cells to deliver a fully functional human AP4M1 cDNA copy via intrathecal inj…

Spasticity, MuscleMicrocephalyIntellectual Deficiency+3 more